Key to symbols
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
4.1. Hypnotics and anxiolytics
4.1.1.2. Hypnotics for chronic insomnia
Total Formulary
DARIDOREXANT (Quviviq)
Restrictions:
Restricted to use in patients where sleep hygiene advice has been unsuccessful and the use of cognitive behavioural therapy for insomnia (CBT-I) has failed or for whom CBT-I is unsuitable or unavailable.
Prescribing Notes:
- For the treatment of adult patients with chronic insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.
- Sleepio® is a six-week programme based on CBT-I. Sleepio® is used to treat insomnia and is available free on the NHS. For more information visit Sleep | NHS inform
MELATONIN
Restrictions:
Restricted to initiation as recommended by secondary care and in concordance with the NHSGGC 'Melatonin for acute and chronic insomnia in adults' treatment guideline.
Prescribing Notes:
Melatonin should be prescribed in generic form. Approved medicinal forms include:
- Melatonin 2mg modified-release tablets
- Melatonin 3mg immediate-release tablets
- Melatonin 1mg in 1ml oral solution